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(Abstract) 
Aim of review, and review question: The aim of this review was to gather comprehensive 
knowledge on HIV mother-to-child transmission prevention and describe current preventative 
methods. What are the current methods in preventing Mother to Child HIV transmissions in 
healthcare resource limited areas? – was the question the review sought to answer. 
Method: A literature review of current research and recommended applications on the field in 
suppressing the spread of HV with CINAHL and PUBMED databases used as main sources of 
research articles.  
Preventative measures (results): The results were grouped into general themes that covered: 
Good nutrition, prophylactic combination therapy, preventing micro-transfusions risks between 
foetus and mother by avoiding invasive procedure on foetus, and preventing contact/ duration of 
contact between infant and mother’s blood and other bodily fluids. The methods of prevention 
include: Antiretroviral suppression of viral load in blood and mucus secretion in birth canal, 
Minimise delay between membrane rupture and birth, Treating ulcerative STDs before delivery, 
C-section birth (extremely costly), and Exclusive breastfeeding in absence of suitable and 
affordable formula feeding. 
Nursing considerations: There are different levels of poverty in resource-limited areas which 
affect prevention of MTCT. Nurses should give individualised education about prevention. 
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HIV- TARTUNTOJEN ENNALTAEHKÄISY ÄIDILTÄ 
LAPSELLE KÖYHILLÄ ALUEILLA - 
KIRJALLISUUSKATSAUS 
Tiivistelmä 
Katsauksen tarkoitus ja tutkimuskysymys: Katsauksen tarkoituksena oli koota kattavasti yhteen tietoa 
keinoista ehkäistä HIV-tartunnan siirtymistä äidiltä lapselle ja kuvailla ajankohtaisia menetelmiä tartuntojen 
estämiseksi. Mitkä ovat nykyiset keinot ehkäistä HIV-tartuntojen siirtymistä äidiltä lapselle vähäisten 
terveydenhuolto resurssien puitteissa? Katsauksen tarkoituksena oli vastata tähän kysymykseen.  
Menetelmä: Kirjallisuuskatsaus tämänhetkiseen alan tutkimukseen ja toimintasuosituksiin koskien HV:n 
leviämisen estämistä, hyödyntäen pääasiassa artikkeleita CINAHL- ja PUBMED-tietokannoista.  
Ehkäiseviä keinoja (tulokset): Saadut tulokset koottiin pääteemoittain, sisältäen seuraavat aihealueet: hyvä 
ravitsemus, profylaktinen yhdistelmähoito, sikiön ja äidin välisten mikroverensiirtojen riskien vähentäminen 
välttäen sikiötä vahingoittavia toimenpiteitä, ja lapsen ja äidin veren ja muiden ruumiinnesteiden kontaktin 
välttäminen tai kontaktin keston vähentäminen. Tartunnan ehkäisemisen menetelmiin kuuluu: 
antiretroviraalinen virusmäärän tukahduttaminen synnytyskanavan veren- ja limanerityksessä, sikiökalvon 
puhkeamisen ja syntymän välisen ajan minimointi, haavaisten sukupuolitautien hoitaminen ennen 
synnytystä, keisarileikkaus (äärimmäisen kallis vaihtoehto), ja yksinomainen imetys sopivien ja edullisten 
äidinmaidonkorvikkeiden puuttuessa.  
Huomioita hoitotyöhön: Vähäisten ja rajoitettujen resurssien alueilla ilmenee monen tasoista köyhyyttä, mikä 
vaikuttaa äidiltä lapselle siirtyvien tartuntojen ehkäisyyn. Sairaanhoitajien tulisi antaa yksilöityä koulutusta 
ennaltaehkäisemisestä. 
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1 INTRODUCTION 
The pandemic of the acquired immune deficiency syndrome (AIDS) is caused by 
the human immunodeficiency virus type 1 (HIV-1). There are two main strains of 
HIV: HIV-1 which is the more common type and has caused the majority of infec-
tions and AIDS cases and is what is usually implied when mention of HIV is made 
generally. HIV-2 is a rarer form of the virus and is concentrated in selected coun-
tries mainly in West Africa. Given the simplicity of the virus, they mutate much 
more easily than more complex forms of life and hence have been known to differ 
from individual to individual and even to mutate within an individual over the 
course of the disease. There are other more obscure forms of the virus in humans 
and primates but these two are responsible for the global epidemic (WHO 2016.) 
AIDS represents one of the most serious health crises in the world; there are 34 
million people infected worldwide, with more than 15.4 million about half of the 
population being women (WHO 2014). The growth of AIDS cases among women 
has as a consequence, the increase in mother-to-child transmission (MTCT) of 
HIV infection hence MTCT is considered the most common etiology for pediatric 
AIDS. Almost all AIDS cases in children under 13 years of age have vertical trans-
mission of HIV as their source of infection (Cruz et al. 2013). Without preventive 
interventions approximately one-third of infants born to HIV-positive mother’s 
contract the virus, becoming infected during their mother’s pregnancy, childbirth 
or breastfeeding. The rate of MTCT transmission of HIV, without any intervention, 
stands at around 25.5%, and it is possible to reduce this to levels between 0% 
and 2%, by means of preventive interventions. (Cruz et al. 2013.) 
Currently, HIV infection is incurable. However effective antiretroviral (ARV) drugs 
can control the virus and help prevent transmission. Also the risk of MTCT can 
be reduced by interventions that include ARV prophylaxis given to women during 
pregnancy and labour and to the infant in the first weeks of life. Recently WHO 
advised HIV-positive mothers to avoid breastfeeding if they were able to afford, 
prepare and store formula milk safely. With these interventions it is good news 
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that new HIV infection among children were reduced by 58% from 2000-2014 in 
the western world. (UNAIDS 2015.) 
On the other hand, 95% of vertical transmission of HIV occurs in resource limited 
areas. Every minute an infected infant is born in spite of the fact that vertical 
transmission is largely preventable, mainly because translating knowledge into 
practice is not always feasible. This has led to continuous growing numbers of 
children with HIV, thereby making pediatric HIV a looming problem rapidly drain-
ing the already burdened health care system of these countries. (Lala & Merchant 
2010.) 
Resource limited areas although not strictly limited to economically poor countries 
are in most cases synonymous with them. They are usually characterised by crip-
pling levels of financial poverty which the World Bank defines as anyone living on 
below USD 1.90 per day adjusted for regional variations in purchasing power 
(The World Bank 2015). These countries also rank low on the human develop-
ment index which measures not just income levels but uses quality of life 
measures to gauge the level of human development. For example, life span, lev-
els of education, and infant mortality rates (UNDP 2015). Resource limited coun-
tries are characterised by insufficient levels of adequately equipped healthcare 
facilities such as hospitals and clinics and shortage of well-trained personnel to 
staff then or provide education at the community level. They are also plagued by 
high level of illiteracy and health related challenges making the need for research 
into disease prevention in such locations necessary for advancing global pros-
perity. Most are located in Africa, South America and Asia. They are sometimes 
referred to as developing countries. 
The aim of this literature review is to find out HIV MTCT preventive methods cur-
rently in use in resource-limited areas. At the same time, deepening the 
knowledge by understanding those common factors that affect prevention of 
mother to child transmission (PMTCT) of HIV and synthesise the evidence-based 
knowledge. 
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2 BACKGROUND 
 MTCT also referred to as vertical transmission is the transmission of the HIV 
virus from mother to the child. This transmission occurs at an estimated rate of 
15 to 30% in developed countries and increases to 30 to 45% in developing coun-
tries representing as the major cause of AIDS in children (Lala & Merchant 2010). 
The transmission can occur at three different times; Prepartum (in uterus), due to 
feto-maternal blood shunts within the placenta; Intrapartum (during delivery), 
when neonates pass through the birth canal and are exposed to infected maternal 
blood and genital secretions and Postpartum: during breastfeeding which ac-
counts for up to 40% of infant infections because both cell-free and cell-associ-
ated viruses have been detected in breast milk. (Da Silva et al. 2013; Milligan & 
Overbaugh 2014.) 
A breach in the maternal-infant blood barrier, otherwise known as placental micro 
transfusion is believed to facilitate MTCT. The exact cause of placental micro 
transfusions still remains unknown, they have been associated with contractions 
during the early stages of labor when membranes rupture and ultimately result in 
the exchange of small amounts of maternal and fetal blood. This exchange may 
result in the transfer of HIV-infected cells from the mother to child, increasing 
infection risk for the infant. Furthermore, a majority of transmission events are 
believed to occur across infant mucosal surfaces, such as gastrointestinal tract 
and nasopharyngeal surfaces. Throughout gestation, delivery, and the breast-
feeding these mucosal barriers are in constant contact with HIV-infected maternal 
fluids providing sufficient time and chance for transmission to occur. (Milligan & 
Overbaugh 2014.) 
The risk of HIV transmission from mother to child is the highest at the end of 
pregnancy and the vast majority of infections are occurring during labour and 
delivery. Generally the risk of infection in prepartum period is at 20%, during de-
livery is 45-50% and 30-35 % in the post-partum period. In industrialized nations 
the risk is at 15-25 % and that of developing countries is 25-45%. This difference 
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is largely caused by transmission by breastfeeding by HIV positive women in the 
developing countries. (Weinberg 2000.)  
Sexually transmitted diseases can lead to vaginal ulceration which can increase 
the amount of HIV infected fluid in the birth canal. Maternal tuberculosis has also 
been shown to be associated with increased risk of mother to child transmission. 
Research undertaken in India showed an almost threefold increase in transmis-
sion rates between tuberculosis infected HIV positive mother and child (30%) rel-
ative to HIV-positive non-tuberculosis infected mother and child pairs (12%). 
(Gupta et al 2011.) 
Malnutrition resulting in nutrient deficiency during pregnancy causes deterioration 
in the overall health of the mother reducing the level of immune response to the 
presence of the HIV virus. Reduced viral suppression means increased plasma 
viral load and reduced effectiveness of antiretroviral therapy thus increasing the 
risk of vertical transmission. 
This review seeks to add to the existing body of knowledge available for nursing 
students and other professionals involved in the prevention of the spread of HIV.  
As implied in the term “review”, the aim is to “look again” at what has been found, 
said and written about the vertical transmission of HIV and to apply recommended 
academic practices in producing a paper of scientific nature.  
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3 THE PURPOSE, AIM AND RESEARCH QUESTION 
The purpose is to gather comprehensive knowledge on HIV mother to child trans-
mission prevention and describe current preventative methods. 
This review seeks to add to the existing body of knowledge available for nursing 
student and other professionals involved in the prevention of the spread of HIV.  
As implied in the term “review”, the aim is to “look again” at what has been found, 
said and written about the vertical transmission of HIV and to apply recommended 
academic practices in producing a paper of scientific nature.  
This review discusses practices in both developed and developing countries but 
the main focus is on resource limited areas also referred to as developing coun-
tries in this review. 
 
The research question is: 
 What are the current methods in preventing Mother to Child HIV transmis-
sions in resource limited areas? 
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4 METHODOLOGY 
Permission for this review was granted by TURUAMK (refer to appendix 1) 
Given the constantly evolving nature of research into HIV and Acquired Immune 
deficiency Syndrome, AIDS, the majority of research articles used were produced 
within the last decade but some landmark articles from the earlier decade which 
influenced the more recent research works were also included to provide a wider 
and longer range view of the topic. Reliability and currency of information is the 
main reason for setting a time limit on the included source materials.  
CINAHL and PUBMED databases were the primary sources of material reviewed 
in this paper. These are of notable merit as sources of reliable scientific research 
publications and access to them was available for the review. Other sources re-
lied on are nursing and medical sciences textbooks.  
The research topic and questions are formulated using the PICO framework of 
Population, Intervention, Comparison, and Outcome. “Mother-to-child”, that is 
HIV positive mothers or soon-to-be mothers are the target study population. “Pre-
vention” looks at the various interventions in the transmission of the virus. Higher 
transmission rates in “resource limited areas” provides a comparison to the suc-
cesses in lowering the rate of transmission if wealthier regions. The targeted out-
come of the question is the result of prevention which is the lower rate of vertical 
transmission.  
Search terms used were “prevent*AND mother-to-child transmission” or “vertical 
transmission AND HIV”. Search terms were truncated to allow for the inclusion of 
more articles. “English”, “2005 to present” (except for landmark articles some of 
which are older) and “full text” were the secondary search limiters used in the 
process (see appendix 2). Given the volume of research articles used in this pro-
cess, a table (see appendix 1) summarizing the relevant projects was produced 
to provide a quick overview and facilitate the data collection process. A column 
on the limitations of included articles was included in the process to provide ob-
jectivity and a large enough sample size of 17 of the most relevant articles were 
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used as basis of the reults and provide adequate coverage of the subject. The 
quality of articles included were graded in decreasing level of reliability: First level 
research report are large randomized control trials (RCT); second studies are 
RCTs with 50 subjects or less; the third level is made up of smaller cohort or 
case-control and cohort studies; forth level evidence come from case reports and 
low-level case-control and cohort studies; and the fifth level is reports based on 
expert or consensus based on experience, physiological or biological principles. 
(Polit & Beck 2012). 
A critical appraisal checklist for assessing included article were (adapted from 
Rew 2010): 
1. Is the research report relevant to HIV MTCT prevention? 
2. What are the research questions and purpose or objects of the paper? 
3. Is the research methodology evidence-based? Does it adequately assess the 
aims of the project?  
4. Is the sample size big enough and relevant to the research aims? 
5. What outcomes does the paper produce? Does it answer the questions it sets 
out to answer? 
6. What are the limitations of the research? 
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5 METHODS OF PREVENTION 
Results from this review are discussed under subtopics of various prevention 
methods used in PMTCT in three phases of pregnancy. Though practice differ 
from country to country, the general recommendations for both the developed 
and developing and resource restrained settings are discussed. However it is im-
portant to note that MTC of HIV-1 may happen at any time of pregnancy, hence 
an understanding of the time and mechanisms of transmission is crucial for de-
signing intervention strategies. 
5.1 Prevention before delivery 
In the pre-delivery phase of pregnancy, the use of ARTs is the major way of re-
ducing MTCTs. Treatment of women and their children with antiretroviral during 
the course of pregnancy and breastfeeding has dramatically lowered the risk of 
MTCT, by reducing maternal viral burden and by providing prophylaxis to the in-
fant. There is a positive link between maternal prenatal viral load and the risk of 
both in utero and intrapartum transmission. (Milligan & Overbaugh 2014, Chap-
pell& Cohn 2014.). ARV drugs suppress viral replication in the body assisting the 
individual's immune system to strengthen and regain the capacity to fight-off in-
fections. WHO recommends that, antiretroviral treatment should begin as soon 
after diagnosis as possible for those who are HIV infected (see appendix 4). 
Providing ART to all pregnant and breast feeding women living with HIV serves 
three synergistic purposes: improving individual health outcomes, preventing 
MTCT of HIV, preventing the horizontal transmission of HIV from the mother to 
an uninfected sexual partner (WHO 2015). 
ARVs also decrease viral mutations and can reduce mother-to-child transmission 
of HIV either by lowering plasma viral load in the mother and providing post-ex-
posure prophylaxis for the newborn. Initially, monotherapy which is the use of a 
single antiretroviral agent  usually consisting of single-dose Nevirapine provided 
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to the mother and infant near birth could decrease transmission by half, presum-
ably by reducing both intrapartum (during labor/delivery) and early breast milk 
infections.(Milligan & Overbaugh 2014.)  
However, monotherapy has shown to lead to HIV drug resistance and the spread 
of resistant strains of the virus is expected to increases with the increasing adop-
tion of antiretroviral therapy. To combat this, the current standard for antiretroviral 
therapy to is highly active antiretroviral therapy (HAART), which is composed of 
three or more antiretroviral agents. Combination therapy as it sometimes referred 
to uses a mixture of Zidovudine, Lamivudine and/or Nevirapine depending on the 
current health situation of the particular patient and their history of HIV treatment 
as appropriately assessed by their health personnel. This form of ART when used 
during pregnancy and breastfeeding can reduce transmission risk to less than 
5% and child morbidity in general. It also leads to a maximization of viral suppres-
sion, increased therapeutic efficiency and durability, and the delaying of the de-
velopment of drug resistance which ultimately leaves more options for future HIV 
therapy open. (Hammer et al. 2008, Schwartz et al. 2015.) However in low- and 
middle-income countries HAART is not always available. Various simpler and 
moderately cheap ART regimens have been provided to pregnant women and 
their newborn babies. The efficiency of such regimes still remains unknown. 
It is recommended that pregnant women currently not on antiretroviral therapy 
start after gestation week 14 and the assessment criteria are same as those for 
non-pregnant patients. Before starting therapy, consideration should be given to: 
the patients consent and willingness, the current HIV viral load, state of her im-
mune system as shown by a CD4+ cell count, and medical history. Socioeco-
nomic factors should also be considered to assess the risk of catching opportun-
istic infections and, the prevention of drug resistance. Improvement of overall ma-
ternal health, quality of life and outlook should be the primary goal of HIV therapy. 
If any reason ART is stopped, all antiretroviral medications should be stopped 
and restarted at the same time. (Madger et al. 2005.) The main way to monitor 
response to ART was through either clinical or immunological (CD4 cell count). 
(WHO 2015.) 
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5.2 Prevention during delivery 
Elective caesarean section (ECS) before the onset of labour has decreased the 
risk of HIV transmission by approximately 50% (Navéér et al. 2011). ECS reduces 
MTCT rates by preventing the neonate from coming into direct contact with in-
fected maternal fluids and secretions during labour since the majority of HIV 
transmission appears to occur near or at the time of delivery when foetal expo-
sure to maternal body fluids is most likely. (Madger et al. 2005). The recommen-
dation is that ECS is carried out before the mother goes into labour and mem-
brane rupture and this is to take place at 2-3 weeks before expected date of de-
livery. All ARTs should still be taken in regular doses before the operation and 
antibiotic prophylaxis is same as in non HIV infected mothers (Navéér et al. 2011) 
ECS is beneficial compared to vaginal delivery because the risk of transmission 
may increase during complicated vaginal delivery, for instance when instrumental 
procedures are necessary, when labour is prolonged, or when a long time passes 
between the rupture of the membranes and delivery. These complications are 
more common in first time deliveries. Practicalities such as the possibility of prior 
planning, daytime delivery and the availability of experienced staff, are factors in 
favour of an elective caesarean section (Navéér et al. 2011). 
Vaginal delivery is not recommended for HIV infected mothers however given the 
cost and risk of complications such as thrombosis, infection and hemorrhage in-
volved in any major operation, and the lack of resources to manage such compli-
cations especially in developing countries, the routine use of caesarean sections 
may not provide an increase benefit when post-operational mortality rates are 
taken into account  In such inevitable cases ways to increase the safety of vaginal 
birth are of particular relevance. The requirement is that the mother should have 
no history of previous uncomplicated vaginal deliveries, and should be on a well-
functioning antiretroviral treatment, with undetectable viral load and no obstetric 
risk factors.  
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Reducing the viral load in the vaginal canal during vaginal birth significantly re-
duces the risk of intra-partum transmission of HIV. HAART has proven to signifi-
cantly lower the level of HIV viral load in vaginal discharges hence reduces the 
risk of transmission. In effect, discussions have taken place to determine whether 
elective caesarean section is still necessary to mothers who have had HAART 
and have a possibly lower transmission rate because of undetectable viral load 
that has been reached through HAART regimes. (Navéér et al. 2011.) 
5.3 Prevention after delivery 
WHO recommends all mothers, regardless of their HIV status to practice Exclu-
sive breastfeeding( EBF) ´´which means no other liquids or food are given – in 
the first six months of life to achieve optimal growth, development, and health’’. 
Thereafter infants should receive nutritionally adequate and safe complementary 
foods while breastfeeding continues up to 24 months or beyond. However, given 
the need to reduce the risk of HIV transmission to infants and minimizing the risk 
of other causes of morbidity and mortality, the guidelines also state that “when 
replacement feeding is acceptable, feasible, affordable, sustainable, and safe”, 
Exclusive Formula Feeding (EFF) which implies avoidance of breastfeeding by 
HIV-infected mothers is recommended.(WHO 2010.) Hence in the developed 
countries where healthy and affordable replacement formula feeding is available 
HIV positive mothers are strongly counselled not to breastfeed their infants. Thus 
infants are fed with formula milk or donated breast milk while at the same time 
the mother receives anti-lactation medication. This seems to be the surest way 
to prevent infants from contacting maternal virus in breastmilk.(HIV tukikeskus 
2015.)  
On the other hand, in developing countries where there is the societal context of 
unsafe water and unsanitary or nutritionally deficient home-modified animal milk 
substitutes resulting in risks of infant death due to diseases such as diarrhea and 
malnutrition coupled with high costs of breast prohibitive milk substitutes as well 
17 
 
as risk of stigmatization that accompanies not breastfeeding, EBF has been rec-
ognized and remains the only feasible and sustainable option for the infant to 
receive the nutrients and antibodies needed to survive. For an individual HIV-
infected mother, it is a very challenging situation to balance the risks and benefits. 
A study in Brazil reported that even though majority of participants, 29 out of 30 
had adopted EFF they were faced with challenges: difficulty reconciling their per-
ceptions that breastfeeding is an important maternal responsibility, trouble ac-
cepting that breastfeeding can cause potential to harm their infants, confronting 
HIV-related stigma associated with EFF, and unexpected financial burdens due 
to EFF. (Maccarthy et al. 2013). Reasons resulting in non- adherence to EBF in 
a study conducted in Kenya included demographic and socioeconomic factors, 
breastfeeding complications such as mastitis and mothers limited knowledge on 
express milk for babies while they are away.(Koima et al. 2014). Postpartum 
counselling for HIV-positive women which includes information about the risks 
and benefits of various infant feeding options based on local assessment and 
guidance in selecting the most suitable option for their situation. Proper feeding 
techniques, management of complications such as subclinical mastitis as well as 
psychological support and coping strategies should be covered in these postnatal 
counseling sessions.  Enforcing treatment of clinical mastitis with antibiotics, and 
expressing and discarding breast milk from the affected breast while also contin-
uing feeding from the unaffected breast, and treating infant oral thrush or nipple 
candidiasis with nystatin can all help reduce MTCT of HIV. (Kuortis et al. 2007.) 
HIV viral component in breast milk could also be inactivated either by chemical 
means or heat. A preclinical study of treating breast milk with Sodium dodecyl 
sulphate has shown some promise. Boiling or pasteurization of breast milk ap-
pears to decrease HIV infectivity of milk. Pretoria pasteurization, in which breast 
milk in a glass jar is placed in boiling water for 12-15 minutes, is a simple method 
for maintaining breast milk at 56-62.5°C by heat transfer. This method, which can 
be done in the home has been shown to reduce bacterial contamination of unre-
frigerated breast milk for up to 12 hours. (Kuortis et al. 2007) 
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5.4 Factors that influence PMTCT 
In addition to those clinical risks factors mentioned above, there are other con-
siderations that also have an effect on PMTCT. In this part, some main issues 
that result in successful PMTCT are discussed. 
5.4.1 Male partner 
It is one key factor in PMTCT that significantly influences the effectiveness of HIV-
positive women’s adherence to antiretroviral therapy during and after pregnancy 
(Hampanda 2014). Therefore, male involvement plays an important role in 
PMTCT (Tilahun & Mohammed 2015; Hampanda 2016). According to the study 
conducted in 2015 with the sample n=700 in Ethiopia, 53% of them were found 
to be involved in PMTCT (Tilahun & Mohamed 2015). This level of involvement 
is higher than other studies from East Africa (Semrau et al.2005), in Uganda 
(Sarker et al 2007), only 16% of the sample participate in PMTCT and male in-
volvement is correlated with increased uptake of HIV testing and preventive in-
tervention for vertical and sexual transmission. In a similar study in Kenya 
(Tweheyo et al. 2010) male involvement only accounts for 15% of the sample. It 
was shown that women accompanied by their partner for HIV testing were three 
time more likely to return for antiretroviral prophylaxis. ( according to Tilahun & 
Mohamed 2015.) 
In the cases of intimate partner violence, there was a decrease in adherence to 
PMTCT during and after pregnancy in Uganda. The way adherence to PMTCT 
was effected by intimate partner violence differed by violence types. Emotional 
and sexual violence had a more pronounced effect on non-adherence than phys-
ical violence. Experiencing physical violence decreases the rate of adherence to 
infant prophylaxis after delivery (62% with n=320). While women suffering from 
emotional violence had a 90% reduced chance of adherence to their medication, 
as well as 90% reduced chance of giving the infant prophylaxis. (Hampanda 
2016.) 
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5.4.2 Health care workers 
PMTCT has been regarded as a comprehensive set of interventions that demand 
capable health workers (Aishat & Olubunmi 2016). It is obvious that health work-
ers play an important role in the successful achievement of PMTCT. In a study 
carried between 2009 and 2012, of the 1105 mother-infant pairs included, 264 
(23.9%) received community based support (CBS). Those who got CBS had im-
proved antenatal ART initiation, initiated ART and Zidovudine with less delay, and 
the risk of stillbirth was lowered. (Fatti et al. 2016.) In line with these findings, the 
use of peers, community lay persons and village health team members resulted 
in a significant rise in six-week postnatal follow-up of HIV infected women and 
early infant HIV diagnosis in urban and rural health units in Uganda. (Namukwaya 
et al. 2015.) 
However, appropriate implementation of PMTCT services demands adequate 
knowledge and appropriate attitudes and practices on the part of the health care 
providers especially in rural areas where access to health care delivery is very 
limited (Aishat & Olubunmi 2016).  Knowledge level of HIV/AIDS –PMTCT along 
with respondents’ background (including marital status, sex, time spent in the 
current hospital and religion) showed no significant correlation except the fact 
that health care workers who were Christian were two times more likely to be 
knowledgeable about PMTCT than the Muslims one. This religion findings are in 
line with the study published in Ghana (Boateng et al 2013, according to Aisha & 
Olubunmi 2016). At the same time, respondents who had worked less than 5 
years in the current hospital were four times less knowledgeable than those who 
had spent more than 5 years and they were three times less likely to have good 
attitude towards PMTCT as well (Aishat & Olubunmi 2016).  
Many HIV-affected individuals and couples want to reproduce. However lack of 
information and knowledge can cause fear. Hence, the role of the healthcare pro-
vider in providing information and resources is to help them safely conceive while 
minimizing the risk of sexual and perinatal HIV transmission (Mmeje et al. 2016.) 
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5.4.3 Early detection of maternal HIV infection 
Good assessment of the risks of MTCT HIV infection in resource limited areas 
can result in reducing child morbidity and mortality rates as well as reinforcing 
PMTCT. Testing pregnant women for HIV, if possible during their first pregnancy 
visit is the first step for PMTCT. (Wudine & Damtew 2016.)  Early detection of 
maternal HIV infection in pregnancy focused on voluntary counselling and testing 
as the primary means of providing testing and foster people to turn into concerned 
of their HIV status (Baset 2002, according to Abtew et al. 2015). A study con-
ducted in Brazil revealed that low level of antenatal screening and access to 
PMTCT were major limitations in the PMTCT (Patrico et al, 2015). 
5.4.4  Other factors 
HIV-infected mother’s knowledge of HIV MTCT also plays a crucial role to the 
success of PMTCT. HIV infected women are found to be more knowledgeable of 
MTCT and PMTCT than those who are not (56%vs 45% with n=10299 in an 
investigation from 2011-2012 in Tanzania) (Haile et al. 2016). However 
knowledge about HIV/AIDS and PMTCT may not be sufficient to guarantee 
behavioral change (Abtew et al. 2015). 
Food insecurity is also a factor that may influence PMTCT. Food insecurity is de-
fined as “the lack of physical, social, and economic access to sufficient food for 
dietary needs and food preferences”. However food insecurity was not associated 
with maternal or infant receipt of ARV prophylaxis although the same study found 
that there may be a link when food insecurity is severe. Among HIV-exposed 
infants, 13.3% of those born to women who reported severe household food 
insecurity were HIV infected compared to 8.2% of infants whose mothers reported 
food secure household (n=8790 women). (McCoy et al. 2015.) 
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6 DISCUSSION 
In undertaking this  review, we sought to understand two main things: where cur-
rent research stands on vertical transmission of HIV in developed countries and 
resource limited regions and how that compares to on-going practices on the field 
and recommendations from international agencies such as the United Nations 
and its various branches. Our review considered best practices in general and 
how evidence-based practice is implemented.  
Although the use of ART during pregnancy and post-delivery gives strong public 
health benefits in term of parental health and PMTCT, the possible long-term 
harm for fetal and infant exposure to maternal drug is badly understood (WHO 
2015). A review article published in Sweden suggests that ART treatment some-
times causes adverse effects, e.g. gastrointestinal problems, anaemia and fa-
tigue to the mother; these can be particularly difficult to evaluate and manage 
during pregnancy, since the same symptoms are typical of pregnancy itself. Gen-
erally, the effect of short-term exposure to antiretroviral drugs on the progression 
of disease in HIV-infected women is not known. Nor is the long-term effect of fetal 
exposure to antiretroviral nucleoside analogues, although many infants born now 
to HIV-infected mothers are exposed during intrauterine and early neonatal life. 
There is a scarcity of data on the pharmacokinetics and safety of agents other 
than Zidovudine during pregnancy. The safety of antiretroviral drugs is a key is-
sue for the management of HIV-infected pregnant women. It was recently re-
ported that there might be an increased risk of premature delivery associated with 
the use of combination therapy during pregnancy, especially when protease in-
hibitors were included. Three cases of lactic acidosis resulting in maternal deaths 
and four non-fatal cases in pregnant women have been reported; all the women 
received a combination of ARV’s. (Navéér et al. 2011.) 
A significant issue this paper highlights is the need to reduce infant and maternal 
mortality while preventing the transmission of the human immunodeficiency virus. 
Guidelines on breastfeeding without the constraint of resource limitation states 
that breastfeeding should be completely avoided and the baby should be fed on 
22 
 
infant formula that meets the nutritional needs of the child (Boer et al. 2010). In 
parts of the world where optimized alternative infant nutrition can be provided 
regularly and of suitable quality, this is straightforward. But infant formula of the 
right quality and quantity is beyond the reach of most families in resource-poor 
areas where even portable water is unavailable. In such a situation, exclusive 
breastfeeding provides a higher chance of survival than the high risk of mortality 
resulting from malnutrition and infection resulting from the consumption of un-
clean water. (WHO 2016.) 
The treatment of ulcerative sexually transmitted illnesses before delivery has also 
proven to be effective and a method of prevent vertical transmission. Ulcers in 
the vaginal increase the present blood and mucus membranes secretions. The 
increased amount of virus-rich blood or other secretions increases the risk of 
transmission. (Celum et al. 2004). Thus, antenatal screening for other sexually 
transmitted diseases would be a cost-effective method of prevention.  
The role of adequate maternal nutrition in prevention of HIV transmission cannot 
be overstated. Poor maternal nutrition decreases immune resilience leading to 
an increased rate of disease progression (Maayer & Saloojee 2011). The weaker 
the mother’s immune system is, the more advance the stage of the infection and 
the higher the viral load in the blood secretions of the mucus membranes in the 
birth canal, proportionately increasing the chances of infected the baby. Invasive 
procedures on the fetus must be avoided as these might break the mother-child 
blood barrier and lead to pre-partum infection.  
Limiting infant exposure to infected maternal fluids (including blood, cervicovagi-
nal fluid, and breast milk has been shown to reduce the risk of MTCT Similarly, 
ECS conducted prior to the onset of labor and membrane rupture, avoid infant 
exposure in the birth canal and reduce risk of transmission.(Milligan, Overbaugh 
2014) 
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6.1  Limitations of review process  
Language of search: All article included in the review were in English thus ex-
cluding all research published in other languages. Given that significant amount 
of research into HIV is carried out in non-English speaking regions of Africa, Asia 
and South America, this excludes findings from a great portion of the world that 
is involved in the topic. 
Inexperience of researchers: Although guidelines and procedures are followed as 
closely as possible, none of the researchers involved in the collection and syn-
thesis of information to produce this paper had research backgrounds. That limi-
tation might show in the overall quality and presentation of the results. Our inex-
perience also showed in the lack of proper time management and project plan-
ning. More training, practice and implementation of lessons learnt is necessary 
before undertaking future projects 
Database access: Due to the nature of the agreements between the Turku Uni-
versity of Applied Sciences and the database services providers, full access to 
all articles was not possible thus necessitating the rejection of some relevant ones 
for lack of availability of full texts or necessity for further payments to be made 
before. 
6.2 Conclusion 
Within resource limited areas, people live and experience different levels of pov-
erty and resource deprivation and hence have access to varying levels of 
healthcare and health education. Nurses in general, and those working in such 
areas in particular must be aware of the specific circumstance of the person seek-
ing their care in order for them to be able to provide assistance that is relevant to 
the needs of the person. Thus providing individualized care should be the main 
focus of nursing care in such areas. Future research should focus on the side 
effects of ARV,s on both mothers and their infants. Both long term and short term 
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complications on mothers and infants as well as fetal exposure to these ARV,s 
are also important issues that could be considered. 
 
25 
 
REFERENCE 
1. Arvold, N.D., Ngo-Giang-Huong, N., McIntosh, K., Suraseranivong, V., 
Warachit, B., Piyaworawong, S., Changchit, T., Lallemant, M. & Jourdain, 
G. 2007, "Maternal HIV-1 DNA load and mother-to-child transmission", 
AIDS Patient Care & STDs, vol. 21, no. 9, pp. 638-643 6p.  
2. Catherine A. Chappell & Susan E. Cohn, 2014 Prevention of Perinatal 
Transmission of Human Immunodeficiency Virus, Infect Dis Clin N Am 
28(2014) 529-547 
3. Celum, C., Levine, R., Weaver, M. & Waid, A. 2004, "Genital herpes and 
human immunodeficiency virus: double trouble", Bulletin of the World 
Health Organization, vol. 82, no. 6, pp. 447-453 7p.  
4. Cruz Rodrigues, S.T., Rodrigues Vaz, M.J. & Oliveira Barros, S.M. 2013, 
"Vertical transmission of HIV in the population treated at a reference cen-
ter", Acta Paulista de Enfermagem, vol. 26, no. 2, pp. 158-164 7p.  
5. da Silva, R.C., Bedin, E., Mangano, A., Aulicino, P., Pontillo, A., Brandão, 
L., Guimarães, R., Arraes, L.C., Sen, L. & Crovella, S. 2013, "HIV mother-
to-child transmission: A complex genetic puzzle tackled by Brazil and Ar-
gentina research teams", Infection, Genetics and Evolution, vol. 19, pp. 
312-322. 
6. De Maayer, T. & Saloojee, H. 2011, "Clinical outcomes of severe malnu-
trition in a high tuberculosis and HIV setting", Archives of Disease in Child-
hood, vol. 96, no. 6, pp. 560-564 5p.  
7. European Collaborative Study, Boer K, England K, Godfried MH, Thorne 
C. 2010, "Mode of delivery in HIV-infected pregnant women and preven-
tion of mother-to-child transmission: changing practices in Western Eu-
rope", HIV Medicine, vol. 11, no. 6, pp. 368-378 11p.  
8. Fa’tima Rejane Lemos Patrico, George Williams Rutherford, Jose’  Hen-
rique Silva Barreto, Cynthia Rodamilans, Roberto Badaro .2015, “Effec-
tiveness of the prevention of mother-to-child HIV transmission in Bahia, 
Brazil”, The Brazilian Journal of Infectious Diseases, 2015;19(5): 538-542 
26 
 
9. Fisseha Wudineh and Bereket Damtew. 2016, “Mother-to-Child Transmis-
sion of HIV Infection and Its Determinants among Exposed Infants on Care 
and Follow-Up in Dire Dawa City, Eastern Ethiopia”, AIDS Research and 
Treatment, Volume 2016 (2016), Article ID 3262746, 6 pages 
10. Graham SM, Holte SE, Peshu NM, Richardson BA, Panteleeff DD, Jaoko 
WG, et al. 2007 “In Initiation of antiretroviral therapy leads to a rapid de-
cline in cervical and vaginal HIV-1 shedding”. AIDS 2007;21:501 – 7.  
11. Geoffrey Fatti, Najma Shaikh, Brian Eley&Ashraf Gimwood. 2016, “Effec-
tiveness of community-based support for pregnant women living with HIV: 
a cohort study in South Africa”, AIDS Care, DOI: 
10.1080/09540121.2016.1148112 
12. Gupta, A., Bhosale, R., Kinikar, A., Gupte, N., Bharadwaj, R., Kagal, A., 
Joshi, S., Khandekar, M., Karmarkar, A., Kulkarni, V., Sastry, J., Mave, V., 
Suryavanshi, N., Thakar, M., Kulkarni, S., Tripathy, S., Sambarey, P., Patil, 
S., Paranjape, R. & Bollinger, R.C. 2011, "Maternal tuberculosis: a risk 
factor for mother-to-child transmission of human immunodeficiency virus", 
Journal of Infectious Diseases, vol. 203, no. 3, pp. 358-363 6p.  
13. Hammer, S.M., Eron, J.,Jr, Reiss, P., Schooley, R.T., Thompson, M.A., 
Walmsley, S., Cahn, P., Fischl, M.A., Gatell, J.M., Hirsch, M.S., Jacobsen, 
D.M., Montaner, J.S., Richman, D.D., Yeni, P.G. & Volberding, P.A. 2008, 
"Antiretroviral treatment of adult HIV infection: 2008 recommendations of 
the International AIDS Society-USA panel", JAMA: Journal of the Ameri-
can Medical Association, vol. 300, no. 5, pp. 555-570 16p.  
14. John, G.C., Nduati, R.W., Mbori-Ngacha, D.A., Richardson, B.A., Pantel-
eeff, D., Mwatha, A., Overbaugh, J., Bwayo, J., Ndinya-Achola, J.O. & 
Dreiss, J.K. 2001, "Correlates of mother-to-child human immunodeficiency 
virus type 1 (HIV-1) transmission: association with maternal plasma HIV-1 
RNA load, genital HIV-1 DNA shedding, and breast infections", Journal of 
Infectious Diseases, vol. 183, no. 2, pp. 206-212 7p.  
15. Jourdain, G., Mary, J., Coeur, S.L., Ngo-Giang-Huong, N., Yuthavisuthi, 
P., Limtrakul, A., Traisanthit, P., McIntosh, K. & Lallemant, M. 2007, "Risk 
27 
 
factors for in utero or intrapartum mother-to-child transmission of human 
immunodeficiency virus type 1 in Thailand", Journal of Infectious Dis-
eases, vol. 196, no. 11, pp. 1629-1636 8p.  
16. Karen M. Hampanda (2016) Intimate partner violence and HIV –positive 
women’s non adherence to antiretroviral medication for the purpose of pre-
vention of mother-to child transmission in Lusaka, Zambia, Social Science 
& Medicine 153 (2016) 123-130. 
17. Kouanda, S., Tougri, H., Cisse, M., Simpore, J., Pietra, V., Doulougou, B., 
Ouedraogo, G., Ouedraogo, C.M., Soudre, R. & Sondo, B. 2010, "Impact 
of maternal HAART on the prevention of mother-to-child transmission of 
HIV: results of an 18-month follow-up study in Ouagadougou, Burkina 
Faso", AIDS Care, vol. 22, no. 7, pp. 843-850 8p.  
18. Koima, W., Kimani, H. & Mwaniki, P. 2014, "Adherence to exclusive 
breastfeeding among HIV-positive women in Nairobi, Kenya", African 
Journal of Midwifery & Women's Health, vol. 8, no. 2, pp. 66-72 7p. 
19. Kuhn, L., Steketee, R.W., Weedon, J., Abrams, E.J., Lambert, G., Bamji, 
M., Schoenbaum, E., Farley, J., Nesheim, S.R., Palumbo, P., Simonds, 
R.J. & Thea, D.M. 1999, "Distinct Risk Factors for Intrauterine and Intra-
partum Human Immunodeficiency Virus Transmission and Consequences 
for Disease Progression in Infected Children", The Journal of Infectious 
Diseases, vol. 179, no. 1, pp. 52-58.  
20. Lala, M.M. & Merchant, R.H. 2010, "Vertical Transmission of HIV-An Up-
date", Indian journal of pediatrics, vol. 77, no. 11, pp. 1270-1276 7p. 
21. Landesman, S.H., Kalish, L.A., Burns, D.N., Minkoff, H., Fox, H.E., Zorrilla, 
C., Garcia, P., Fowler, M.G., Mofenson, L. & Tuomala, R. 1996, "Obstetri-
cal factors and the transmission of human immunodeficiency virus type 1 
from mother to child", New England Journal of Medicine, vol. 334, no. 25, 
pp. 1617-1623 7p.  
22. Lee, M.J., Hallmark, R.J., Frenkel, L.M. & Del Priore, G. 1998, "Maternal 
syphilis and vertical perinatal transmission of human immunodeficiency vi-
rus type-1 infection", International Journal of Gynaecology and Obstetrics, 
vol. 63, no. 3, pp. 247-52.  
28 
 
23. Lynn Rew. 2010, The systematic review of literature: Synthesizing evi-
dence for practice, Journal of Specialists in Pediatric Nursing, DOI: 
10.1111/j. 1744-6155.2010.00270.x 
24. Magder, L.S., Mofenson, L., Paul, M.E., Zorrilla, C.D., Blattner, W.A., 
Tuomala, R.E., LaRussa, P., Landesman, S. & Rich, K.C. 2005, "Risk Fac-
tors for In Utero and Intrapartum Transmission of HIV", Journal of Ac-
quired Immune Deficiency Syndromes, vol. 38, no. 1, pp. 87-95.  
25. Milligan, C. & Overbaugh, J. 2014, "The role of cell-associated virus in 
mother-to-child HIV transmission", Journal of Infectious Diseases, vol. 
210, pp. S631-40 1p. 
26. Maccarthy, S., Rasanathan, J.J.K., Nunn, A. & Dourado, I. 2013, "'I did 
not feel like a mother': The success and remaining challenges to exclu-
sive formula feeding among HIV-positive women in Brazil", AIDS Care, 
vol. 25, no. 6, pp. 726-731 6p. 
27. Marelign Tilahun and Shikur Mohamed. 2015, “Male Partners’ Involvement 
in the prevention of Mother-To-Child Transmission of HIV and Associated 
factors in Arba Minch Town and Arba Minch Zuria Woreda, Southern Ethi-
opia”, Hindawi Publishing Corporation, BioMed Research International, 
Volume 2015, Article ID 763876, 6 pages 
28. Mmeje et al. 2016 “Achieving Pregnancy Safely in HIV-Affected Individuals 
and Couples: An Important Strategy to Eliminate HIV Transmission From 
Mother-To-Child and Between Sexual Partners”, JAIDS Journal of Ac-
quired Immune Deficiency Syndromes, 1 December 2015, Vol. 70-Issue 
4: p e155-e159 
29. Navéér, L., Albert, J., Belfrage, E., Flamholc, L., Gissléén, M., Gyllensten, 
K., Josephson, F., Karlströöm, O., Lindgren, S., Pettersson, K., Svedhem, 
V., Söönnerborg, A., Westling, K. & Yilmaz, A. 2011, "Prophylaxis and 
treatment of HIV-1 infection in pregnancy: Swedish Recommendations 
2010", Scandinavian Journal of Infectious Diseases, vol. 43, no. 6, pp. 
411-423 13p 
30. Pat A. Tookey, Claire Thorne, Jean van Wyk and Micheal Norton. 2016 
“Maternal and foetal outcomes among 4118 women with HIV infection 
29 
 
treated with lopinavir/ritonavir during pregnancy: analysis of population-
based surveillance data from the national study of HIV in pregnancy and 
childhood in the United Kingdom and Ireland”, BMC infectous Diseases 
(2016) 16:65, DOI 10.1186/s 12879-016-1400-y 
31. Pelletier, D.L., Jr, F.E. & Habicht, J. 1993, "Epidemiologic evidence for a 
potentiating effect of malnutrition on child mortality", American Journal of 
Public Health, vol. 83, no. 8, pp. 1130-1133 4p.  
32. Polit, D.F. & Beck, C.T. 2012, Nursing research : generating and assessing 
evidence for nursing practice, 9. ed. edn, Wolters Kluwer Health/Lippincott 
Williams & Wilkins, Philadelphia.  
33. Sandra I McCoy et al. 2015 “Food Insecurity is a barrier to prevention of 
mother to child HIV transmission services in Zimbabwe: a cross-sectional 
study”, BMC Public Health 2015 15:420 DOI: 10.1186/S12889-015-1764-
8 
34. Sheree R. Schwartz, Newton Kumwenda, Johnstone Kumwenda, Shu 
Chen, Lynne M. Mofenson, Allan W. Taylor, Mary Glenn Fowler, Taha E. 
Taha, 2016, “Maternal Highly Active Antiretroviral Therapy and Child HIV-
Free Survival in Malawi, 2004-2009” Matern Child Health J, DOI: 
10.1007/s10995-015-1852-5 
 
35. Solomon Abtew, Worku Awoke and Anemaw Asrat. 2015 “Hiv Testing As 
An Intervention For Prevention Of Mother To Child Transmission Of Hiv 
And Associated Factors Among Pregnant Women Attending At Public 
Health Facilities In Assossa Town, Northwest Ethiopia”, BMC Res Notes 
(2015) 8:661, DOI 10.1186/S13104-015-1652-4 
36. Sperling, R.S., Shapiro, D.E., Coombs, R.W., Todd, J.A., Herman, S.A., 
McSherry, G.D., O'Sullivan, M.J., Van Dyke, R.B., Jimenez, E., Rouzioux, 
C., Flynn, P.M. & Sullivan, J.L. 1996, "Maternal viral load, zidovudine treat-
ment, and the risk of transmission of human immunodeficiency virus type 
1 from mother to infant", New England Journal of Medicine, vol. 335, no. 
22, pp. 1621-1629 9p.  
30 
 
37. Usman Aishat and Ayinde Olubunmi. 2016, “Prevention of Mother-to-Child 
Transmission of HIV/AIDS: Perception of Health care workers in rural Ar-
eas of Oyo State”. Hindawi Publishing Corporation, Scientifia, Volume 
2016, Article ID 4257180, 5 pages 
38. Van Dyke, R.B., Korber, B.T., Popek, E., Macken, C., Widmayer, S.M., 
Bardeguez, A., Hanson, I.C., Wiznia, A., Luzuriaga, K., Viscarello, R.R. & 
Wolinsky, S. 1999, "The Ariel Project: a prospective cohort study of mater-
nal-child transmission of human immunodeficiency virus type 1 in the era 
of maternal antiretroviral therapy [corrected] [published erratum appears 
in J INFECT DIS 1999 Mar; 179(3): 754]", Journal of Infectious Diseases, 
vol. 179, no. 2, pp. 319-328 10p.  
39. Weinberg, G.A. 2000, "The dilemma of postnatal mother-to-child transmis-
sion of HIV: to breastfeed or not?", Birth: Issues in Perinatal Care, vol. 27, 
no. 3, pp. 199-205 7p 
40.  Namukwaya Z, Barlow-Mosha L, Mudiope P, Kekitiinwa A, Matovu JN, 
Musingye E, Ssebaggala JN, Nakyanzi T, Abwooli JJ, Mirembe D, Etima 
J, Bitarakwate E, Fowler MG, Musoke PM. 2015, “Use of peers, commu-
nity lay persons and Village health team (VHT) members improves six-
week postnatal clinic  (PNC) follow-up and early infant HIV diagnosis (EID) 
in urban and rural health units in Uganda: a one year implementation 
study”, BMC Health Service Research (2015) 15: 555 DOI 
10.1186/s12913-015-1213-5->full name 
41. Zelalem T. Haile, Asli K.Teweldeberhan & Ilana R.A. Chertok. 2016, “Cor-
relates of women’s knowledge of mother-to-child transmission of HIV and 
its prevention in Tanzania: a population-based study”, AIDS Care, 28:1, 
70-78, DOI: 10.1080/09540121.2015.1062465 
 
Internet sources 
42. WHO guidelines (2015) Guideline on when to start antiretroviral therapy 
and on pre-exposer prophylaxis for HIV-assessed on 27.4.2016  
http://apps.who.int/iris/bitstream/10665/186275/1/9789241509565_eng.pdf 
31 
 
 
 
43. The World Bank 2015, 10/04/2015-last update, The World bank Forecasts 
Global Poverty to Fall Below 10 per cent for First time; Major Hurdles Re-
main in Goal to End Poverty by 2030-assessed on 11.3.2016 
http://www.worldbank.org/en/news/press-release/2015/10/04/world-bank-
forecasts-global-poverty-to-fall-below-10-for-first-time-major-hurdles-re-
main-in-goal-to-end-poverty-by-2030  
44. UNDP 2015,  Human Development Reports- assessed on 11.3.2016 
http://hdr.undp.org/en/humandev 
45. World Health Organisation 2016, HIV/AIDS-assessed on 11.3.2016 
http://www.who.int/hiv/abouthiv/en/  
46. World Health Organisation. 2010. Guidelines on HIV and infant feeding 
2010 Principles and recommendations for infant feeding in the context of 
HIV and a summary of evidence – assessed on 25.1.2016 
http://www.who.int/maternal_child_adolescent/docu-
ments/9789241599535/en/ 
47. HIV and AIDS statistics - http://hivtukikeskus.fi/en/hiv-and-aids-statistics, 
assessed on 17.2.2016 
48. WHO 2014 http://www.who.int/topics/hiv_aids/en, assessed on 17.2.2016 
49. UNSAID-assessed on 4.3.2016 http://www.unaids.org/en/resources/cam-
paigns/HowAIDSchangedeverything/factsheet  
50.  World Health Organisation- assessed on 27.4.2016 
 http://www.who.int/mediacentre/factsheets/fs360/en/  
 
 
32 
 
APPENDICES 
Table 1: Database search results 
 
 
 
 
 
 
 
 
 
 
 
33 
 
Table 2: Summary of research articles 
 
 
 
34 
 
 
 
 
35 
 
 
 
 
 
 
 
36 
 
 
 
 
 
37 
 
 
 
 
 
 
 
 
 
 
  
 
 
38 
 
 
Table 3: Thesis commission form 
 
39 
 
 
 
40 
 
Table 4: Recommendation for antiretroviral (ARV) regimens for the prevention of 
MTCT of HIV-1 (WHO 2010) 
 
3TC  Lamivudine, Epivir    
AZT  Azidothymidine 
EFV Efavirenz  
FTC  Emtricitabine, Emtriva 
LPV Lopinavir 
NVP Nevirapine  
TDF Tenofovir Disoproxil 
Fumarate 
 
 
